首页
文献索引
SCI期刊
AI助手
搜索
首页
正文
Comment on "Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study"
{{output}}
请注册登录后继续浏览